Rodrigo DeAntonio (Karla Ojeda-Diezbarroso)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Venues

Human vaccines & immunotherapeutics

Therapeutic advances in infectious disease

Journal of market access & health policy

PloS one

Cevaxin

Instituto Nacional de Salud Pública (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cevaxin Aug 1o 2018

Panama

Executive and Scientific Director

Education History

Instituto Nacional de Salud Pública Aug 1o 2014 - Aug 30o 2018

Mexico

PHD :: Salud Publica

Publications

José Antonio Suarez, Dianik Moreno, Juan Miguel Pascale, Lorena Romero, Néstor Sosa, Fergie Ruiz, Rodrigo DeAntonio, Alberto Cumbrera, Carlos Franco-Paredes, José Anel González
Detection of Mansonella ozzardi in peripheral blood in two malaria-endemic areas in Panama. Therapeutic advances in infectious disease 9 (2022)
Rodrigo DeAntonio, Gerardo Amaya-Tapia, Gabriela Ibarra-Nieto, Gloria Huerta, Silvia Damaso, Adrienne Guignard, Melanie de Boer
Incidence of dengue illness in Mexican people aged 6 months to 50 years old: A prospective cohort study conducted in Jalisco. PloS one 16 (5) (2021)
Adriana Guzmán-Holst, Eliana de Barros, Pilar Rubio, Rodrigo DeAntonio, Otavio Cintra, Ariane Abreu
Impact after 10-year use of pneumococcal conjugate vaccine in the Brazilian national immunization program: an updated systematic literature review from 2015 to 2020. Human vaccines & immunotherapeutics (2021)
Gabriel Carrasquilla, Alexandra Porras Ramírez, Sandra Martinez, Rodrigo DeAntonio, Raghavendra Devadiga, Carla Talarico, Diana C Caceres, Maria M Castrejon, Patricia Juliao
Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia. Human vaccines & immunotherapeutics 17 (4) (2020)
Baudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, Alen Marijam, Jorge A Gomez, Lijoy Varghese, Sharon Zhang
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future. Journal of market access & health policy 8 (1) (2020)
Javier Nieto Guevara, Dorota Borys, Rodrigo DeAntonio, Adriana Guzmán-Holst, Bernard Hoet
Interchangeability between pneumococcal conjugate vaccines for pediatric use: a systematic literature review. Expert review of vaccines 19 (11) (2019)
Gilberto Sánchez González, Patricia Juliao, Roberto Carreño-Manjarrez, Andrés Castañeda-Prado, Maria Yolanda Cervantes-Apolinar, Ricardo Cortes-Alcala, Rodrigo DeAntonio
Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines. Human vaccines & immunotherapeutics 15 (6) (2018)
Rodrigo DeAntonio, Sylvia Amador, Eveline M Bunge, Jennifer Eeuwijk, David Prado-Cohrs, Javier Nieto Guevara, Maria Del Pilar Rubio, Eduardo Ortega-Barria
Vaccination herd effect experience in Latin America: a systematic literature review. Human vaccines & immunotherapeutics 15 (1) (2018)
Hugo López-Gatell, Lourdes García-García, Gabriela Echániz-Avilés, Pablo Cruz-Hervert, María Olamendi-Portugal, Deyanira Castañeda-Desales, Miguel Ángel Sanchez-Alemán, Martin Romero-Martínez, Rodrigo DeAntonio, Maria Yolanda Cervantes-Apolinar, Ricardo Cortes-Alcala, Celia Alpuche-Aranda
Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) results. Human vaccines & immunotherapeutics 15 (2) (2018)
Mercedes Macias-Parra, Miguel Angel Rodriguez-Weber, Sarbelio Moreno-Espinosa, Berenice Ceron-Trujillo, Rodrigo DeAntonio, Ricardo Cortes-Alcala, Gustavo Martinez, Roberto Carreño-Manjarrez, Rodolfo Norberto Jiménez-Juárez
Economic burden of varicella complications in two referral centers in Mexico. Human vaccines & immunotherapeutics 14 (12) (2018)

Rodrigo DeAntonio.css-eqlu8i{font-size:small;padding-left:4px;} (Karla Ojeda-Diezbarroso)

Publication Activity (10 Years)

Top Topics

Top Venues

Rodrigo DeAntonio (Karla Ojeda-Diezbarroso)